Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Cancer-associated fibroblasts (CAFs) promote the lymph node metastasis of esophageal squamous cell carcinoma.

Kashima H, Noma K, Ohara T, Kato T, Katsura Y, Komoto S, Sato H, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T.

Int J Cancer. 2018 Oct 27. doi: 10.1002/ijc.31953. [Epub ahead of print]

PMID:
30367467
2.

[The Elucidation of Tumor Immunosuppression Affected by Cancer-Associated Fibroblasts].

Kato T, Noma K, Katsura Y, Sato H, Kohmoto S, Ninomiya T, Ohara T, Tazawa H, Kagawa S, Shirakawa Y, Fujiwara T.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1279-1281. Japanese.

PMID:
30237368
3.

Integrated fluorescent cytology with nano-biologics in peritoneally disseminated gastric cancer.

Watanabe M, Kagawa S, Kuwada K, Hashimoto Y, Shigeyasu K, Ishida M, Sakamoto S, Ito A, Kikuchi S, Kuroda S, Kishimoto H, Tomida S, Yoshida R, Tazawa H, Urata Y, Fujiwara T.

Cancer Sci. 2018 Oct;109(10):3263-3271. doi: 10.1111/cas.13760. Epub 2018 Sep 23.

4.

Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment.

Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, Shirakawa Y, Fujiwara T.

Clin Cancer Res. 2018 Oct 1;24(19):4820-4833. doi: 10.1158/1078-0432.CCR-18-0205. Epub 2018 Jun 19.

PMID:
29921731
5.

HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer.

Kubota T, Kuroda S, Kanaya N, Morihiro T, Aoyama K, Kakiuchi Y, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Fujiwara T.

Nanomedicine. 2018 Aug;14(6):1919-1929. doi: 10.1016/j.nano.2018.05.019. Epub 2018 Jun 8.

PMID:
29885899
6.

Comparison of Atypical and Osteoporotic Femoral Shaft Fractures in the Elderly: A Multicenter Study.

Miura T, Kijima H, Ishikawa N, Ebina T, Tani T, Chida S, Suzuki T, Yumto S, Tazawa H, Miyakoshi N, Shimada Y.

Adv Orthop. 2018 May 16;2018:1068053. doi: 10.1155/2018/1068053. eCollection 2018.

7.

Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.

Ohira M, Kobayashi T, Hashimoto M, Tazawa H, Abe T, Oshita A, Kohashi T, Irei T, Oishi K, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO).

Int J Surg. 2018 Jun;54(Pt A):156-162. doi: 10.1016/j.ijsu.2018.04.058. Epub 2018 May 3.

PMID:
29730072
8.

Hematology from embryo to adult in the bobwhite quail (Colinus virginianus): Differential effects in the adult of clutch, sex and hypoxic incubation.

Flores-Santin J, Rojas Antich M, Tazawa H, Burggren WW.

Comp Biochem Physiol A Mol Integr Physiol. 2018 Apr;218:24-34. doi: 10.1016/j.cbpa.2018.01.005. Epub 2018 Jan 31.

PMID:
29369792
9.

Iron depletion is a novel therapeutic strategy to target cancer stem cells.

Ninomiya T, Ohara T, Noma K, Katsura Y, Katsube R, Kashima H, Kato T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Chen L, Kasai T, Seno M, Matsukawa A, Fujiwara T.

Oncotarget. 2017 Oct 12;8(58):98405-98416. doi: 10.18632/oncotarget.21846. eCollection 2017 Nov 17.

10.

Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system.

Aoyama K, Kuroda S, Morihiro T, Kanaya N, Kubota T, Kakiuchi Y, Kikuchi S, Nishizaki M, Kagawa S, Tazawa H, Fujiwara T.

Sci Rep. 2017 Oct 26;7(1):14177. doi: 10.1038/s41598-017-14717-x.

11.

[Novel Therapeutic Strategy for Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer].

Kanaya N, Kuroda S, Kubota T, Morihiro T, Kikuchi S, Nishizaki M, Tazawa H, Kagawa S, Fujiwara T.

Gan To Kagaku Ryoho. 2017 Oct;44(10):883-885. Japanese.

PMID:
29066684
12.

Characterisation of human induced pluripotent stem cell-derived endothelial cells under shear stress using an easy-to-use microfluidic cell culture system.

Ohtani-Kaneko R, Sato K, Tsutiya A, Nakagawa Y, Hashizume K, Tazawa H.

Biomed Microdevices. 2017 Oct 9;19(4):91. doi: 10.1007/s10544-017-0229-5.

PMID:
28994005
13.

Acute diffuse peritonitis due to spontaneous rupture of a primary gastrointestinal stromal tumor of the jejunum: A case report.

Sato K, Tazawa H, Fujisaki S, Fukuhara S, Imaoka K, Hirata Y, Takahashi M, Fukuda S, Kuga Y, Nishida T, Sakimoto H.

Int J Surg Case Rep. 2017;39:288-292. doi: 10.1016/j.ijscr.2017.08.041. Epub 2017 Aug 23.

14.

Relationship between clinical results of total hip replacement and postoperative activities including weeding and snow shovelling.

Kijima H, Yamada S, Konishi N, Kubota H, Tazawa H, Tani T, Suzuki N, Kamo K, Okudera Y, Sasaki K, Kawano T, Miyakoshi N, Shimada Y.

Hip Int. 2018 Mar;28(2):145-147. doi: 10.5301/hipint.5000537. Epub 2017 Jul 9.

PMID:
28885646
15.

Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.

Tazawa H, Kuroda S, Hasei J, Kagawa S, Fujiwara T.

Int J Mol Sci. 2017 Jul 10;18(7). pii: E1479. doi: 10.3390/ijms18071479. Review.

16.

Role of zoledronic acid in oncolytic virotherapy: Promotion of antitumor effect and prevention of bone destruction.

Yamakawa Y, Tazawa H, Hasei J, Osaki S, Omori T, Sugiu K, Komatsubara T, Uotani K, Fujiwara T, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Cancer Sci. 2017 Sep;108(9):1870-1880. doi: 10.1111/cas.13316. Epub 2017 Aug 3.

17.

A colovesical fistula with a persistent descending mesocolon due to partial situs inversus: A case report.

Mochizuki T, Tazawa H, Hirata Y, Kuga Y, Miwata T, Fukuhara S, Imaoka K, Fujisaki S, Takahashi M, Fukuda S, Nishida T, Sakimoto H.

Int J Surg Case Rep. 2017;37:109-112. doi: 10.1016/j.ijscr.2017.06.029. Epub 2017 Jun 17.

18.

Effect of Fc-γ Receptor Polymorphism on Rituximab-Mediated B Cell Depletion in ABO-Incompatible Adult Living Donor Liver Transplantation.

Sakai H, Tanaka Y, Tazawa H, Shimizu S, Verma S, Ohira M, Tahara H, Ide K, Ishiyama K, Kobayashi T, Onoe T, Ohdan H.

Transplant Direct. 2017 May 24;3(6):e164. doi: 10.1097/TXD.0000000000000683. eCollection 2017 Jun.

19.

A Case of Fracture-Redislocation of the Hip Caused by a Depressed Fracture of the Femoral Head Similar to a Hill-Sachs Lesion.

Okudera Y, Kijima H, Yamada S, Konishi N, Kubota H, Tazawa H, Tani T, Suzuki N, Kamo K, Sasaki K, Kawano T, Iwamoto Y, Miyakoshi N, Shimada Y.

Case Rep Orthop. 2017;2017:7409153. doi: 10.1155/2017/7409153. Epub 2017 May 18.

20.

A case of pancreatic schwannoma showing increased FDG uptake on PET/CT.

Fukuhara S, Fukuda S, Tazawa H, Imaoka K, Mochizuki T, Hirata Y, Fujisaki S, Takahashi M, Nishida T, Sakimoto H.

Int J Surg Case Rep. 2017;36:161-166. doi: 10.1016/j.ijscr.2017.05.031. Epub 2017 Jun 1.

21.

GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

In Vitro Cell Dev Biol Anim. 2017 Jun;53(6):479-482. doi: 10.1007/s11626-017-0133-6. Epub 2017 Feb 23. No abstract available.

PMID:
28233141
22.

Dynamics of acid-base and hematological regulation in day 15 chicken embryos (Gallus gallus domesticus) exposed to graded hypercapnia and hypoxia.

Mueller CA, Tazawa H, Burggren WW.

Respir Physiol Neurobiol. 2017 May;239:55-63. doi: 10.1016/j.resp.2017.02.001. Epub 2017 Feb 9.

PMID:
28189709
23.

A solid pseudopapillary neoplasm of the pancreas in a man presenting with acute pancreatitis: A case report.

Chikuie E, Fukuda S, Tazawa H, Nishida T, Sakimoto H.

Int J Surg Case Rep. 2017;31:114-118. doi: 10.1016/j.ijscr.2017.01.026. Epub 2017 Jan 17.

24.

High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

In Vitro Cell Dev Biol Anim. 2017 Apr;53(4):285-287. doi: 10.1007/s11626-016-0117-y. Epub 2017 Jan 26. No abstract available.

PMID:
28127701
25.

OBP-401-GFP telomerase-dependent adenovirus illuminates and kills high-metastatic more effectively than low-metastatic triple-negative breast cancer in vitro.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Cancer Gene Ther. 2017 Feb;24(2):45-47. doi: 10.1038/cgt.2016.67. Epub 2017 Jan 20.

PMID:
28106046
26.

p53 Replacement Therapy for Cancer.

Tazawa H, Kagawa S, Fujiwara T.

Recent Results Cancer Res. 2016;209:1-15. doi: 10.1007/978-3-319-42934-2_1. Review.

PMID:
28101684
27.

Sphincter-saving resection by cluneal arched skin incision for a gastrointestinal stromal tumor (GIST) of the lower rectum: a case report.

Tazawa H, Hirata Y, Kuga Y, Nishida T, Sakimoto H.

Surg Case Rep. 2017 Dec;3(1):8. doi: 10.1186/s40792-016-0285-8. Epub 2017 Jan 5.

28.

Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirus.

Takehara K, Yano S, Tazawa H, Kishimoto H, Narii N, Mizuguchi H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM.

Cell Cycle. 2017 Aug 18;16(16):1502-1508. doi: 10.1080/15384101.2016.1249548. Epub 2017 Jan 5.

29.

Comparison of Tumor Recurrence After Resection of Highly- and Poorly-Metastatic Triple-negative Breast Cancer in Orthotopic Nude-Mouse Models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Fujiwara T, Bouvet M, Hoffman RM.

Anticancer Res. 2017 Jan;37(1):57-60.

PMID:
28011473
30.

In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Anticancer Res. 2016 Dec;36(12):6273-6277.

PMID:
27919946
31.

Tumor-specific delivery of biologics by a novel T-cell line HOZOT.

Onishi T, Tazawa H, Hashimoto Y, Takeuchi M, Otani T, Nakamura S, Sakurai F, Mizuguchi H, Kishimoto H, Umeda Y, Shirakawa Y, Urata Y, Kagawa S, Fujiwara T.

Sci Rep. 2016 Nov 30;6:38060. doi: 10.1038/srep38060.

32.

Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.

Yano S, Takehara K, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Oncotarget. 2016 Dec 20;7(51):85273-85282. doi: 10.18632/oncotarget.13296.

33.

A mixed adenoneuroendocrine carcinoma of the pancreas: a case report.

Imaoka K, Fukuda S, Tazawa H, Kuga Y, Mochizuki T, Hirata Y, Fujisaki S, Takahashi M, Nishida T, Sakimoto H.

Surg Case Rep. 2016 Dec;2(1):133. Epub 2016 Nov 15.

34.

Comparison of in vitro invasiveness of high- and low-metastatic triple-negative human breast cancer visualized by color-coded imaging.

Yano S, Takehara K, Tazawa H, Kishimoto H, Kagawa S, Fujiwara T, Hoffman RM.

In Vitro Cell Dev Biol Anim. 2017 Feb;53(2):96-98. doi: 10.1007/s11626-016-0092-3. Epub 2016 Oct 24. No abstract available.

PMID:
27778228
35.

[Novel HER2-Targeted Therapy Combined with Gold Nanoparticles].

Kubota T, Kuroda S, Morihiro T, Tazawa H, Kagawa S, Fujiwara T.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1237-1239. Japanese.

PMID:
27760946
36.

Cell-cycle-dependent drug-resistant quiescent cancer cells induce tumor angiogenesis after chemotherapy as visualized by real-time FUCCI imaging.

Yano S, Takehara K, Tazawa H, Kishimoto H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM.

Cell Cycle. 2017 Mar 4;16(5):406-414. doi: 10.1080/15384101.2016.1220461. Epub 2016 Aug 11.

37.

Injury of the deep femoral artery penetrating branch caused by the breakage of a greater trochanter fixed cable: Case report.

Suzuki N, Kijima H, Watanabe W, Konishi N, Kubota H, Yamada S, Tazawa H, Tani T, Kamo K, Okudera Y, Sasaki K, Kawano T, Miyakoshi N, Shimada Y.

J Orthop Sci. 2018 Sep;23(5):849-852. doi: 10.1016/j.jos.2016.09.001. Epub 2016 Oct 3. No abstract available.

PMID:
27713007
38.

Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.

Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Oncotarget. 2016 Nov 15;7(46):75635-75647. doi: 10.18632/oncotarget.12314.

39.

Efficacy of a Cell-Cycle Decoying Killer Adenovirus on 3-D Gelfoam®-Histoculture and Tumor-Sphere Models of Chemo-Resistant Stomach Carcinomatosis Visualized by FUCCI Imaging.

Yano S, Takehara K, Tazawa H, Kishimoto H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM.

PLoS One. 2016 Sep 27;11(9):e0162991. doi: 10.1371/journal.pone.0162991. eCollection 2016.

40.

The choice of internal fixator for fractures around the femoral trochanter depends on area classification.

Kijima H, Yamada S, Konishi N, Kubota H, Tazawa H, Tani T, Suzuki N, Kamo K, Okudera Y, Sasaki K, Kawano T, Miyakoshi N, Shimada Y.

Springerplus. 2016 Sep 8;5(1):1512. doi: 10.1186/s40064-016-3206-1. eCollection 2016.

41.

Enhanced Metastatic Recurrence Via Lymphatic Trafficking of a High-Metastatic Variant of Human Triple-Negative Breast Cancer After Surgical Resection in Orthotopic Nude Mouse Models.

Yano S, Takehara K, Tazawa H, Kishimoto H, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

J Cell Biochem. 2017 Mar;118(3):559-569. doi: 10.1002/jcb.25735. Epub 2016 Oct 17.

PMID:
27626220
42.

Successful treatment of primary advanced gastric plasmacytoma using a combination of surgical resection and chemotherapy with bortezomib: A case report.

Fukuhara S, Tazawa H, Okanobu H, Kida M, Kido M, Takafuta T, Nishida T, Ohdan H, Sakimoto H.

Int J Surg Case Rep. 2016;27:133-136. doi: 10.1016/j.ijscr.2016.08.041. Epub 2016 Sep 3.

43.

Iron depletion-induced downregulation of N-cadherin expression inhibits invasive malignant phenotypes in human esophageal cancer.

Nishitani S, Noma K, Ohara T, Tomono Y, Watanabe S, Tazawa H, Shirakawa Y, Fujiwara T.

Int J Oncol. 2016 Oct;49(4):1351-9. doi: 10.3892/ijo.2016.3640. Epub 2016 Jul 29.

PMID:
27499208
44.

In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.

Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM.

Anticancer Res. 2016 Aug;36(8):3817-20.

PMID:
27466482
45.

Ablation of MCL1 expression by virally induced microRNA-29 reverses chemoresistance in human osteosarcomas.

Osaki S, Tazawa H, Hasei J, Yamakawa Y, Omori T, Sugiu K, Komatsubara T, Fujiwara T, Sasaki T, Kunisada T, Yoshida A, Urata Y, Kagawa S, Ozaki T, Fujiwara T.

Sci Rep. 2016 Jun 30;6:28953. doi: 10.1038/srep28953.

46.

Therapeutic Cell-Cycle-Decoy Efficacy of a Telomerase-Dependent Adenovirus in an Orthotopic Model of Chemotherapy-Resistant Human Stomach Carcinomatosis Peritonitis Visualized With FUCCI Imaging.

Yano S, Takehara K, Tazawa H, Kishimoto H, Urata Y, Kagawa S, Fujiwara T, Hoffman RM.

J Cell Biochem. 2017 Nov;118(11):3635-3642. doi: 10.1002/jcb.25593. Epub 2017 Jul 31.

PMID:
27171483
47.

Iron depletion enhances the effect of sorafenib in hepatocarcinoma.

Urano S, Ohara T, Noma K, Katsube R, Ninomiya T, Tomono Y, Tazawa H, Kagawa S, Shirakawa Y, Kimura F, Nouso K, Matsukawa A, Yamamoto K, Fujiwara T.

Cancer Biol Ther. 2016 Jun 2;17(6):648-56. doi: 10.1080/15384047.2016.1177677. Epub 2016 Apr 18.

48.

Fluvoxamine, an anti-depressant, inhibits human glioblastoma invasion by disrupting actin polymerization.

Hayashi K, Michiue H, Yamada H, Takata K, Nakayama H, Wei FY, Fujimura A, Tazawa H, Asai A, Ogo N, Miyachi H, Nishiki T, Tomizawa K, Takei K, Matsui H.

Sci Rep. 2016 Mar 18;6:23372. doi: 10.1038/srep23372.

49.

An Easy-to-Use Polystyrene Microchip-based Cell Culture System.

Tazawa H, Sunaoshi S, Tokeshi M, Kitamori T, Ohtani-Kaneko R.

Anal Sci. 2016;32(3):349-53. doi: 10.2116/analsci.32.349.

50.

Phenotypic developmental plasticity induced by preincubation egg storage in chicken embryos (Gallus gallus domesticus).

Branum SR, Tazawa H, Burggren WW.

Physiol Rep. 2016 Feb;4(4). pii: e12712. doi: 10.14814/phy2.12712.

Supplemental Content

Loading ...
Support Center